AbbVie Inc. (1ABBV)
MTA
Real-time Data
07:00 AM
Day's Range
230.1052 wk Range
163.50Overview - 1ABBV - AbbVie Inc.
Key Statistics
Valuation
Enterprise Value
414.87B
P/E (Trailing)
‪74.58‬
PEG Ratio
‪0.26‬
Price / Sales (TTM)
‪6.34‬
Price / Book
‪-69.38‬
EV / EBITDA
‪15.37‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪9.80%‬
Operating Margin
‪40.03%‬
Return on Assets
‪10.51%‬
Return on Equity
‪-129.67%‬
Ownership
Shares Outstanding
1.76B
Float
1.76B
Held by Insiders
‪0.11%‬
Held by Institutions
‪77.36%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪222.79‬
200-Day Avg
‪198.73‬
Dividends
Payout Ratio
‪190.39%‬
Frequency
Quarterly
Market Cap - 1ABBV - AbbVie Inc.
Peers - 1ABBV - AbbVie Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
Profile Summary - 1ABBV - AbbVie Inc.
About
AbbVie Inc. is a global biopharmaceutical company that develops, manufactures, and commercializes medicines and therapies for complex and serious diseases. AbbVie focuses on major therapeutic areas including immunology, oncology, neuroscience, eye care, aesthetics, and virology, serving patients with chronic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
